Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Immunological and autoimmune disorders 9

Immunological and Autoimmune Disorders

MedTech News and Updates for LivaNova, Medtronic, Conformis, Noninvasix, Masimo

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Noninvasix’s LIVOx™ Central Venous Oxygenation Monitor; LivaNova’s aura6000 System; Oxford BioDynamics’s EpiSwitch® CiRT; Masimo’s SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor; Medtronic’s NuVent™ Eustachian Tube Dilation Balloon; Conformis’s published data for Bilateral Knee Implant Study

Noninvasix Granted the US FDA Breakthrough Device Designation for Non-Invasive Monitoring Technology for Sepsis On February 23, 2022, Noninvasix, Inc. received the US FDA breakthrough device designation for its LIVOx™ Central Venous Oxygenation Monitor. It is a non-invasive device and provides real-time, continuous, or spot monitoring of central venous oxygen saturation (ScvO2) in adults at risk of septic shock. At present there are no non-invasive approaches available that can efficiently provide ScvO2 information with high sensitivity and specificity, nevertheless, Noninvasix will be the first company to non-invasively monitor sepsis by detecting ...

Explore More...

Latest-pharma-news-and-updates

Zydus starts Phase II COVID-19 vaccine trial; Taysha raises $95M; FDA declines DBV’s peanut allergy patch; Combating COVID-19 with decoy target

recent-pharma-news

Kiadis inks license deal with Sanofi; Gilead Ends Hep B Collaboration; Merck & Foghorn inks $425M deal; Tregs research updates

Latest COVID News | Pharma Happenings

HCQ/ CQ failure; AZ/ Catalent’s deal; Sinovac’s CoronaVac and Lilly’s Olumiant trial results

Immune Thrombocytopenia Market

R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia

covid-news

In the fight against COVID-19 – Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit

Bioelectronic Medicine

Bioelectronic Medicine: Applications and Future Prospects

Pharma News

Moderna’s COVID-19 vaccine; AcelRx buys TetraPhase; Breakthrough designation to Baricitinib

Pharma News

JNJ-6372 nabs FDA nods, Solid tumors treatment, Kevzara for COVID-19

Pharma News

First-ever Peanut allergy treatment; Dinutuximab misses primary endpoint; Insmed’s shares Soares

thyroid eye disease

Thyroid awareness month

Thyroid eye disease

Thyroid eye disease market: New therapies enter the TED market

Pharma News

Tepezza receives approval; a new way to treat Alzheimer’s

Pharma news

Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Pharma News

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

pharma news

Eli Lilly to acquire Dermira, Boehringer buys Enleofen’s IL-11 platform, Biogen acquires Pfizer’s Alzheimer’s drug

Egg Allergy Market

Egg Allergy Market: Second most common food allergy but no approved therapy

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly